Literature DB >> 25009382

Non-alcoholic fatty liver disease and thyroid dysfunction: a systematic review.

Ahad Eshraghian1, Alireza Hamidian Jahromi1.   

Abstract

Thyroid hormones are totally involved in the regulation of body weight, lipid metabolism, and insulin resistance. Therefore it is anticipated that thyroid hormones may have a role in the pathogenesis of non alcoholic fatty liver disease (NAFLD) and non alcoholic steatohepatitis (NASH). In this study, we reviewed the current literature on the association between thyroid dysfunction and NAFLD/NASH. A search for English language medical literature reporting an association between thyroid dysfunction and NAFLD/NASH in humans was conducted across PubMed, ISI Web of Science, and Scopus in August, 2013. Out of 140 studies initially identified through the search, 11 relevant articles were included in the final review. Thyroid dysfunctions in the form of overt or subclinical hypothyroidism are prevalent among patients with NAFLD/NASH. Hypothyroidism appears to be an independent risk factor for NAFLD/NASH in some studies; however, other newly published studies failed to find such an association. The results of the studies on the role of thyroid abnormalities in NAFLD/NASH are inconsistent, and further research is recommended to determine the relationship between hypothyroidism and NAFLD/NASH and the underlying mechanisms.

Entities:  

Keywords:  Hypothyroidism; Non alcoholic fatty liver disease; Non alcoholic steatohepatitis; Pathophysiology; Risk factor; Thyroid dysfunction

Mesh:

Substances:

Year:  2014        PMID: 25009382      PMCID: PMC4081681          DOI: 10.3748/wjg.v20.i25.8102

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  69 in total

Review 1.  Nonalcoholic fatty liver disease.

Authors:  Kathryn Law; Elizabeth M Brunt
Journal:  Clin Liver Dis       Date:  2010-11       Impact factor: 6.126

2.  Exenatide decreases hepatic fibroblast growth factor 21 resistance in non-alcoholic fatty liver disease in a mouse model of obesity and in a randomised controlled trial.

Authors:  S L Samson; P Sathyanarayana; M Jogi; E V Gonzalez; A Gutierrez; R Krishnamurthy; R Muthupillai; L Chan; M Bajaj
Journal:  Diabetologia       Date:  2011-09-29       Impact factor: 10.122

3.  Gluco-lipidic indices in treated hypothyroidism associated with nonalcoholic fatty liver disease.

Authors:  Daniel Ferraz de Campos Mazo; Vicência Mara Rodrigues de Lima; Jose Tadeu Stefano; Fabiola Rabelo; Joel Faintuch; Claudia Pinto de Oliveira
Journal:  Arq Gastroenterol       Date:  2011 Jul-Sep

Review 4.  Role of oxidative stress in the pathogenesis of nonalcoholic steatohepatitis.

Authors:  Anabela P Rolo; João S Teodoro; Carlos M Palmeira
Journal:  Free Radic Biol Med       Date:  2011-10-13       Impact factor: 7.376

Review 5.  Non-alcoholic fatty liver disease: a massive problem.

Authors:  Christopher P Day
Journal:  Clin Med (Lond)       Date:  2011-04       Impact factor: 2.659

6.  Prevalence of hypothyroidism in nonalcoholic fatty liver disease.

Authors:  Mangesh R Pagadala; Claudia O Zein; Srinivasan Dasarathy; Lisa M Yerian; Rocio Lopez; Arthur J McCullough
Journal:  Dig Dis Sci       Date:  2011-12-20       Impact factor: 3.199

Review 7.  Thyroid function in childhood obesity and metabolic comorbidity.

Authors:  Lucia Pacifico; Caterina Anania; Flavia Ferraro; Gian Marco Andreoli; Claudio Chiesa
Journal:  Clin Chim Acta       Date:  2011-11-27       Impact factor: 3.786

8.  Insulin sensitivity, plasma adiponectin and sICAM-1 concentrations in patients with subclinical hypothyroidism: response to levothyroxine therapy.

Authors:  Irina Kowalska; Jacek Borawski; Agnieszka Nikołajuk; Tadeusz Budlewski; Elżbieta Otziomek; Maria Górska; Marek Strączkowski
Journal:  Endocrine       Date:  2011-03-18       Impact factor: 3.633

9.  Association between thyroid function and nonalcoholic fatty liver disease in euthyroid elderly Chinese.

Authors:  Chengfu Xu; Lei Xu; Chaohui Yu; Min Miao; Youming Li
Journal:  Clin Endocrinol (Oxf)       Date:  2011-08       Impact factor: 3.478

10.  Circulating fibroblast growth factor 21 levels are closely associated with hepatic fat content: a cross-sectional study.

Authors:  Hongmei Yan; Mingfeng Xia; Xinxia Chang; Qiong Xu; Hua Bian; Mengsu Zeng; Shengxiang Rao; Xiuzhong Yao; Yinfang Tu; Weiping Jia; Xin Gao
Journal:  PLoS One       Date:  2011-09-16       Impact factor: 3.240

View more
  35 in total

1.  Increased apolipoprotein A5 expression in human and rat non-alcoholic fatty livers.

Authors:  Qin Feng; Susan S Baker; Wensheng Liu; Ricardo A Arbizu; Ghanim Aljomah; Maan Khatib; Colleen A Nugent; Robert D Baker; Trudy M Forte; Yiyang Hu; Lixin Zhu
Journal:  Pathology       Date:  2015-06       Impact factor: 5.306

Review 2.  Extra-Hepatic Manifestations of Nonalcoholic Fatty Liver Disease: A Review.

Authors:  Raseen Tariq; Page Axley; Ashwani K Singal
Journal:  J Clin Exp Hepatol       Date:  2019-07-25

Review 3.  Endocrine causes of nonalcoholic fatty liver disease.

Authors:  Laura Marino; François R Jornayvaz
Journal:  World J Gastroenterol       Date:  2015-10-21       Impact factor: 5.742

4.  Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease.

Authors:  Lisa B VanWagner; Mary E Rinella
Journal:  Curr Hepatol Rep       Date:  2016-03-28

5.  Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis.

Authors:  Ahad Eshraghian; Saman Nikeghbalian; Bita Geramizadeh; Seyed Ali Malek-Hosseini
Journal:  United European Gastroenterol J       Date:  2017-04-25       Impact factor: 4.623

6.  Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria.

Authors:  Carolina Castro Porto Silva Janovsky; Fernando H Cesena; Viviane Arevalo Tabone Valente; Raquel Dilguerian de Oliveira Conceição; Raul D Santos; Márcio Sommer Bittencourt
Journal:  Eur Thyroid J       Date:  2018-08-29

7.  Severe Phenotype of Non-alcoholic Fatty Liver Disease in Pediatric Patients with Subclinical Hypothyroidism: a Retrospective Multicenter Study from Korea.

Authors:  So Yoon Choi; Dae Yong Yi; Soon Chul Kim; Ben Kang; Byung Ho Choe; Yoon Lee; Yoo Min Lee; Eun Hye Lee; Hyo Jeong Jang; You Jin Choi; Hyun Jin Kim
Journal:  J Korean Med Sci       Date:  2021-05-24       Impact factor: 2.153

Review 8.  Low-normal thyroid function and novel cardiometabolic biomarkers.

Authors:  Lynnda J N van Tienhoven-Wind; Robin P F Dullaart
Journal:  Nutrients       Date:  2015-02-16       Impact factor: 5.717

9.  FT3/FT4 ratio predicts non-alcoholic fatty liver disease independent of metabolic parameters in patients with euthyroidism and hypothyroidism.

Authors:  Fatma Yahyaoğlu Gökmen; Süleyman Ahbab; Hayriye Esra Ataoğlu; Betül Çavuşoğlu Türker; Faik Çetin; Fatih Türker; Rabia Yahyaoğlu Mamaç; Mustafa Yenigün
Journal:  Clinics (Sao Paulo)       Date:  2016-04       Impact factor: 2.365

Review 10.  Direct effects of thyroid hormones on hepatic lipid metabolism.

Authors:  Rohit A Sinha; Brijesh K Singh; Paul M Yen
Journal:  Nat Rev Endocrinol       Date:  2018-02-23       Impact factor: 43.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.